Mark Horn

Member of Advisory Board for "The Food Finance Conference", to be held in London on May 17, 2012.

"With 9 billion mouths to feed by 2050, sustainable global development can only be made a reality through innovation in technology, business and finance. The inaugural Euromoney Food Conference will bring together the financial community with practitioners from agriculture & related businesses and global policy-makers to discuss and decide how innovation in finance and markets can improve global food supply and security."

Other Advisory Board members:
* Dr Juergen Voegele, Director of Agriculture, World Bank
* The Hon. Kwesi Ahwoi, Minister of Agriculture, Ghana
* Professor Mohan Munasinghe, 2007 Joint Nobel Peace Prize Winner, Vice Chairman of Intergovernmental Panel on Climate Change
* Professor Hélyette Geman, Director, Commodity Finance Centre University of London; Scientific Advisor to the EU on Agricultural Commodities
* Abdirahman Beileh, Director of Agriculture and agro-industry, African Development Bank
* Francis Beddington, Co-Founder, Insparo Asset Management
* Gavin McGillivray, Head of Private Sector Development, Department for International Development, UK Government
* His Excellency Rashid Mohamed Al Shariqi, Chairman, Abu Dhabi Food Control Authority
* Dr. Mahendra Shah, Senior Policy Advisor, Qatar National Food Security Program

South America Session Chair for the "Agricultural Investment Summit Europe", to be held in London, UK on June 26-28, 2012.

"The 5th annual Agriculture Investment Summit will guide you through the complexities of investing in agriculture as an asset class.

Learn how to make the most of exposures in South America, Sub Saharan Africa, Central and Eastern Europe and Australia and New Zealand from Brasil Agro, TIAA-CREF, PKA Pensionskasse and Feronia Inc - Africa during the regional streams.

Meet with the entire agriculture supply chain, from farmers to food companies, to end-investors, during the shared networking breaks with the attendees to the Future Farm Europe conference."

Presented "Investir em inovação aberta numa relação publico-privada", jointly with Dr. C. Wilches of Embrapa.

I worked on an innovation related project at Embrapa headquarters. Previously, as part of my consultancy, I advised the President of Embrapa in the area of technology transfer.

Embrapa is the Brazilian government agricultural research institute founded in 1973. The institute has approx. 10,000 employees, including more than 2,200 research scientists, based at 47 decentralized research units throughout Brazil.

Embrapa is a world leader in tropical agriculture. Among its accomplishments are the transformation of the Cerrado into productive farmland and the tropicalization of soy.

Embrapa's accomplishments have been the subject of many publications, including the October 2010 Washington Post article "Brazilian scientists turning nation into an agro-power", the April 2010 Economist article "The Miracle of the Cerrado" and the October 2007 New York Times article "Scientists Are Making Brazil’s Savannah Bloom".

I served as Chairman of AgriYield 2010: The Central and Eastern European Yield and Optimisation Summit. The conference was held in Prague, Czech Republic in November, 2010.

Speakers included:
* Ülo Adamson, Chairman of Board of Directors, Trigon Agri
* Frans Bastiaanssen, Owner, Basfood
* Simon Boughton, Head of Agriculture, Trigon Agri
* Olivier DuBois, Senior Officer, FAO
* Guy Ellena, Director, IFC/World Bank
* Garlich von Essen, Secretary General, European Seed Assoc.
* Tom Green, CEO, Spearhead International
* Michael Horsch, Managing Director, Horsch Farming
* Euros Jones, Director of Regulatory Affairs, ECPA
* Ton van der. Kleij, Managing Director, Kverneland Group
* Craig Lipawsky, Int´l Product Manager, CNH
* Hubertus M. Mühlhäuser, Senior VP, AGCO
* Karsten Neuffer, Supply Chain Director, Syngenta
* Rodrigo Oliveira, Professor, Federal University of Tocantins
* Christian Pallière, Director Agriculture, Fertilizers Europe
* Jonathan Ramsay, EMEA Public Affairs Lead, Monsanto
* Andrey Sizov Jr., Managing Director, Sovecon
* Vitaliy Skotsyk, CEO, Landkom

* Developed a prospection process to identify products and services for technology transfer from within the research portfolio.

* Implemented the new process in a pilot group of researchers, generating a portfolio of technologies with potential to be protected by patent or other means.

* Trained TT staff in use of the prospection process.

Contracted through the Inter-American Institute for Cooperation on Agriculture (IICA)

The bioLOGIC Europe conference was held in Geneva, Switzerland in September of 2008.

Speakers:
* Dr. Nicholas Davies, Senior Director, Pfizer
* Dr. Tariq Ghavur, Senior Principle Scientist, Abbott Labs
* Dr. William Haddad, Chairman and CEO, Biogenerics Inc.
* Dr. Mick Kolassa, CEO & Managing Partner, MME
* Dr. Roland Kreutzer, CEO & Co-Founder, Roche-Kulmbach
* Edward Madden Esq., Assoc. Dir., Biogen Idec Int´l
* Dr. Glenn Miller, VP & General Manager, Genzyme
* Dr. Walter Moos, Vice President, SRI
* Alon Natanson, CEO, Procognia
* Dr. Bruce Pratt, Vice President, Genzyme Corp.
* Dr. Jean-Marc Renard, Vice President, Sanofi-Pasteur
* Dr. Malcolm Skingle, Director, GlaxoSmithKline
* Dr. Patrick Vink, Senior VP & Head of Biologics, Mylan

The Portfolio Management for Pharma conference was held in Madrid, Spain in February of 2008.

Speakers:
* Kerstin Bode-Greuel, Associate Lecturer, University of Essen
* Manuel Carmona, European Sales Mgr., Palisade-Europe
* Tony Ellery, Global Head, Novartis Pharma
* Kimber Hardy, Senior Director, Merck Serono
* Andre Hoekema, Senior VP, Galapagos
* Roger Holdsworth, Assoc. Director, UCB
* Pasi Piitulainen, Director, Actelion
* Rafaat Rahmani, Founder & President, Lifescience Dynamics
* Eric Rambeaux, Vice President, Solvay
* David Rosen, Development Head, Pfizer
* Bernd Seilheimer, Global Head, Bayer Schering
* Markus Thunecke, Senior Partner, Catenion
* Allan Wehnert, Vice President, H. Lundbeck

Held positions of increasing responsibility over 16 years within the consumer division of Wyeth, maker of leading OTC brands including: Centrum Vitamins®, Advil®, Robitussin® and ChapStick®. Managed annual R&D budget in the range of $100 - $200 million. Appointed by President to design portfolio management process for the division. Managed global innovation and Rx - OTC switch teams. Worked effectively across divisions and departments. Liaison to large and small pharma partners. Prepared new products strategic plan. HR, IT and facilities management for Global Scientific Affairs. Other positions held include: Director Finance and Information Management, Associate Director Project Planning and Administration, Assistant Director Project Planning and Administration and Manager of Medical Communications.

Medical writer and Clinical study manager, Clinical Development Department. Contributed to the successful clinical development of Remeron® (mirtazapine).